Skip to Main Content
S. Karger AG
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 104, Issue 1
November 2016
Issue Cover
All Issues
ISSN 0028-3835
EISSN 1423-0194
In this Issue

Neuroendocrinology 2017, Vol. 104, No. 1

Original Paper

Trends in Incidence of Neuroendocrine Neoplasms in Norway: A Report of 16,075 Cases from 1993 through 2010
Raziye Boyar Cetinkaya; Bjarte Aagnes; Espen Thiis-Evensen; Steinar Tretli; Deidi S. Bergestuen; Svein Hansen
Neuroendocrinology (2016) 104 (1): 1–10. https://doi.org/10.1159/000442207
View articletitled, Trends in Incidence of Neuroendocrine Neoplasms in Norway: A Report of 16,075 Cases from 1993 through 2010
Open the PDF for in another window
Malnutrition Predicts Clinical Outcome in Patients with Neuroendocrine Neoplasia
Sebastian Maasberg; Barbora Knappe-Drzikova; Dorothée Vonderbeck; Henning Jann; Karsten H. Weylandt; Christian Grieser; Andreas Pascher; Jörg C. Schefold; Marianne Pavel; Bertram Wiedenmann; Andreas Sturm; Ulrich-Frank Pape
Neuroendocrinology (2016) 104 (1): 11–25. https://doi.org/10.1159/000442983
View articletitled, Malnutrition Predicts Clinical Outcome in Patients with Neuroendocrine Neoplasia
Open the PDF for in another window
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival
Anja Rinke; Michael Wittenberg; Carmen Schade-Brittinger; Behnaz Aminossadati; Erdmuthe Ronicke; Thomas M. Gress; Hans-Helge Müller; Rudolf Arnold; for the PROMID Study Group
Neuroendocrinology (2016) 104 (1): 26–32. https://doi.org/10.1159/000443612
View articletitled, Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival
Open the PDF for in another window
Combined Administration of Ghrelin and Corticotropin-Releasing Hormone in the Diagnosis of Cushing's Disease
Dragana Miljić; Snežana Polovina; Mirjana Doknić; Sandra Pekić; Marko Stojanović; Milan Petakov; Dragan Micić; Vera Popović
Neuroendocrinology (2016) 104 (1): 33–39. https://doi.org/10.1159/000444281
View articletitled, Combined Administration of Ghrelin and Corticotropin-Releasing Hormone in the Diagnosis of Cushing's Disease
Open the PDF for in another window
Short-Term High-Fat Diet Feeding Provides Hypothalamic but Not Hippocampal Protection against Acute Infection in Male Mice
Mariana Astiz; Olga Pernía; Vicente Barrios; Luis Miguel Garcia-Segura; Yolanda Diz-Chaves
Neuroendocrinology (2016) 104 (1): 40–50. https://doi.org/10.1159/000444527
View articletitled, Short-Term High-Fat Diet Feeding Provides Hypothalamic but Not Hippocampal Protection against Acute Infection in Male Mice
Open the PDF for in another window
Sexually Diergic Trophic Effects of Estradiol Exposure on Developing Bovine Cerebellar Granule Cells
Stefano Montelli; Matteo Suman; Livio Corain; Bruno Cozzi; Antonella Peruffo
Neuroendocrinology (2016) 104 (1): 51–71. https://doi.org/10.1159/000444528
View articletitled, Sexually Diergic Trophic Effects of Estradiol Exposure on Developing Bovine Cerebellar Granule Cells
Open the PDF for in another window
Catecholamine Metabolism Induces Mitochondrial DNA Deletions and Leads to Severe Adrenal Degeneration during Aging
Johannes Friedrich Georg Neuhaus; Olivier Richard Baris; Anne Kittelmann; Katrin Becker; Markus Alexander Rothschild; Rudolf Josef Wiesner
Neuroendocrinology (2016) 104 (1): 72–84. https://doi.org/10.1159/000444680
View articletitled, Catecholamine Metabolism Induces Mitochondrial DNA Deletions and Leads to Severe Adrenal Degeneration during Aging
Open the PDF for in another window
The Clinicopathologic Heterogeneity of Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: Morphological Differentiation and Proliferation Identify Different Prognostic Categories
Massimo Milione; Patrick Maisonneuve; Francesca Spada; Alessio Pellegrinelli; Paola Spaggiari; Luca Albarello; Eleonora Pisa; Massimo Barberis; Alessandro Vanoli; Roberto Buzzoni; Sara Pusceddu; Laura Concas; Fausto Sessa; Enrico Solcia; Carlo Capella; Nicola Fazio; Stefano La Rosa
Neuroendocrinology (2016) 104 (1): 85–93. https://doi.org/10.1159/000445165
View articletitled, The Clinicopathologic Heterogeneity of Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: Morphological Differentiation and Proliferation Identify Different Prognostic Categories
Open the PDF for in another window
NADPH-Diaphorase Colocalizes with GPER and Is Modulated by the GPER Agonist G1 in the Supraoptic and Paraventricular Nuclei of Ovariectomized Female Rats
Daniela Grassi; Natalia Lagunas; Helena Pinos; GianCarlo Panzica; Luis Miguel Garcia-Segura; Paloma Collado
Neuroendocrinology (2016) 104 (1): 94–104. https://doi.org/10.1159/000445190
View articletitled, NADPH-Diaphorase Colocalizes with GPER and Is Modulated by the GPER Agonist G1 in the Supraoptic and Paraventricular Nuclei of Ovariectomized Female Rats
Open the PDF for in another window
The impact of SGLT2 inhibitors on dementia onset in patients with type 2 diabetes - A meta-analysis of cohort studies
Maternal diet and vulnerability to cognitive impairment in adulthood: possible link with Alzheimer’s disease?
Temozolomide treatment in refractory pituitary adenomas and pituitary carcinomas
Survivin as a therapeutic target for neuroendocrine neoplasms
  • Online ISSN 1423-0194
  • Print ISSN 0028-3835
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal